These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

807 related articles for article (PubMed ID: 19619003)

  • 1. Long-term expansion and pluripotent marker array analysis of Wharton's jelly-derived mesenchymal stem cells.
    Nekanti U; Rao VB; Bahirvani AG; Jan M; Totey S; Ta M
    Stem Cells Dev; 2010 Jan; 19(1):117-30. PubMed ID: 19619003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pluripotent gene expression in mesenchymal stem cells from human umbilical cord Wharton's jelly and their differentiation potential to neural-like cells.
    Tantrawatpan C; Manochantr S; Kheolamai P; U-Pratya Y; Supokawej A; Issaragrisil S
    J Med Assoc Thai; 2013 Sep; 96(9):1208-17. PubMed ID: 24163998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
    Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
    Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional module analysis reveals differential osteogenic and stemness potentials in human mesenchymal stem cells from bone marrow and Wharton's jelly of umbilical cord.
    Hsieh JY; Fu YS; Chang SJ; Tsuang YH; Wang HW
    Stem Cells Dev; 2010 Dec; 19(12):1895-910. PubMed ID: 20367285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New emerging potentials for human Wharton's jelly mesenchymal stem cells: immunological features and hepatocyte-like differentiative capacity.
    Anzalone R; Lo Iacono M; Corrao S; Magno F; Loria T; Cappello F; Zummo G; Farina F; La Rocca G
    Stem Cells Dev; 2010 Apr; 19(4):423-38. PubMed ID: 19958166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stage-specific embryonic antigen 4 in Wharton's jelly-derived mesenchymal stem cells is not a marker for proliferation and multipotency.
    He H; Nagamura-Inoue T; Tsunoda H; Yuzawa M; Yamamoto Y; Yorozu P; Agata H; Tojo A
    Tissue Eng Part A; 2014 Apr; 20(7-8):1314-24. PubMed ID: 24279891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Wharton's Jelly-Derived Stem Cells Display a Distinct Immunomodulatory and Proregenerative Transcriptional Signature Compared to Bone Marrow-Derived Stem Cells.
    Donders R; Bogie JFJ; Ravanidis S; Gervois P; Vanheusden M; Marée R; Schrynemackers M; Smeets HJM; Pinxteren J; Gijbels K; Walbers S; Mays RW; Deans R; Van Den Bosch L; Stinissen P; Lambrichts I; Gyselaers W; Hellings N
    Stem Cells Dev; 2018 Jan; 27(2):65-84. PubMed ID: 29267140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of human mesenchymal stem cells from fetal-bone marrow, adipose tissue, and Warton's jelly as sources of cell immunomodulatory therapy.
    Wang Q; Yang Q; Wang Z; Tong H; Ma L; Zhang Y; Shan F; Meng Y; Yuan Z
    Hum Vaccin Immunother; 2016; 12(1):85-96. PubMed ID: 26186552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defined three-dimensional culture conditions mediate efficient induction of definitive endoderm lineage from human umbilical cord Wharton's jelly mesenchymal stem cells.
    Al Madhoun A; Ali H; AlKandari S; Atizado VL; Akhter N; Al-Mulla F; Atari M
    Stem Cell Res Ther; 2016 Nov; 7(1):165. PubMed ID: 27852316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced neuro-therapeutic potential of Wharton's Jelly-derived mesenchymal stem cells in comparison with bone marrow mesenchymal stem cells culture.
    Drela K; Lech W; Figiel-Dabrowska A; Zychowicz M; Mikula M; Sarnowska A; Domanska-Janik K
    Cytotherapy; 2016 Apr; 18(4):497-509. PubMed ID: 26971678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promising new potential for mesenchymal stem cells derived from human umbilical cord Wharton's jelly: sweat gland cell-like differentiative capacity.
    Xu Y; Huang S; Ma K; Fu X; Han W; Sheng Z
    J Tissue Eng Regen Med; 2012 Aug; 6(8):645-54. PubMed ID: 21916019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive selection of Wharton's jelly-derived CD105(+) cells by MACS technique and their subsequent cultivation under suspension culture condition: A simple, versatile culturing method to enhance the multipotentiality of mesenchymal stem cells.
    Amiri F; Halabian R; Dehgan Harati M; Bahadori M; Mehdipour A; Mohammadi Roushandeh A; Habibi Roudkenar M
    Hematology; 2015 May; 20(4):208-16. PubMed ID: 25116042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of human mesenchymal stem cells isolated by explant culture method from entire umbilical cord and Wharton's jelly matrix.
    Hendijani F; Sadeghi-Aliabadi H; Haghjooy Javanmard S
    Cell Tissue Bank; 2014 Dec; 15(4):555-65. PubMed ID: 24532125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial differentiation of Wharton's jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells.
    Chen MY; Lie PC; Li ZL; Wei X
    Exp Hematol; 2009 May; 37(5):629-40. PubMed ID: 19375653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common expression of stemness molecular markers and early cardiac transcription factors in human Wharton's jelly-derived mesenchymal stem cells and embryonic stem cells.
    Gao LR; Zhang NK; Ding QA; Chen HY; Hu X; Jiang S; Li TC; Chen Y; Wang ZG; Ye Y; Zhu ZM
    Cell Transplant; 2013; 22(10):1883-900. PubMed ID: 23394400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and proliferation of umbilical cord tissue derived mesenchymal stem cells for clinical applications.
    Van Pham P; Truong NC; Le PT; Tran TD; Vu NB; Bui KH; Phan NK
    Cell Tissue Bank; 2016 Jun; 17(2):289-302. PubMed ID: 26679929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human chorionic-plate-derived mesenchymal stem cells and Wharton's jelly-derived mesenchymal stem cells: a comparative analysis of their potential as placenta-derived stem cells.
    Kim MJ; Shin KS; Jeon JH; Lee DR; Shim SH; Kim JK; Cha DH; Yoon TK; Kim GJ
    Cell Tissue Res; 2011 Oct; 346(1):53-64. PubMed ID: 21987220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal plasticity of human Wharton's jelly mesenchymal stromal cells to the dopaminergic cell type compared with human bone marrow mesenchymal stromal cells.
    Datta I; Mishra S; Mohanty L; Pulikkot S; Joshi PG
    Cytotherapy; 2011 Sep; 13(8):918-32. PubMed ID: 21696238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and Functional Verification of Wharton's Jelly Mesenchymal Stem Cells (WJ-MSCs) Pluripotency.
    Musiał-Wysocka A; Kot M; Sułkowski M; Badyra B; Majka M
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wharton's jelly mesenchymal stromal/stem cells derived under chemically defined animal product-free low oxygen conditions are rich in MSCA-1(+) subpopulation.
    Devito L; Badraiq H; Galleu A; Taheem DK; Codognotto S; Siow R; Khalaf Y; Briley A; Shennan A; Poston L; McGrath J; Gentleman E; Dazzi F; Ilic D
    Regen Med; 2014; 9(6):723-32. PubMed ID: 25431909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.